Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Recruiting 4Unknown 3Completed 3Withdrawn 2Active not recruiting 2Suspended 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1

Conditions

Colorectal Neoplasms 2Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × Cell Count × Clear all
NCT05213195 2024-02-12

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

Zhejiang University

Phase 1 Unknown
38 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05248048 2022-02-21

NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer

The Third Affiliated Hospital of Guangzhou Medical University

Phase EARLY_PHASE1 Unknown
9 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03648697 2020-08-11

EBV-TCR-T(YT-E001)for Patients With EBV-positive Recurrent or Metastatic NPC

Fujian Cancer Hospital

Phase 2 Unknown
20 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡